Viewing nowCombinationGlafomin M Tablet 1/500 mg
Metformin Hydrochloride 500mg · Glimepiride 1mg
Tablet · Prescription medication · Combination
Yuhan Corporation

MFDS item code 201107227 · Approved 2011.09.27 · Insurance code 642104100
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help control blood sugar in patients with type 2 diabetes. Glymepride and Metformin work together to effectively lower and control blood sugar levels. It is suitable for patients who require blood sugar control and improves blood sugar management with consistent use.
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.
This medication can cause severe lactic acidosis or hypoglycemia, so it should be temporarily discontinued and discussed with a doctor in cases of rapidly declining kidney function or dehydration symptoms. This medication should not be used in patients with a kidney function below 45 mL/min/1.73 m², and elderly patients or those taking medications that affect kidney function should have their kidney function regularly monitored. As it may increase the risk of cardiovascular disease, cardiovascular status should be carefully monitored while taking this medication. This medication should not be given to patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, pregnant or breastfeeding women, and certain renal impairments. Patients at high risk for hypoglycemia, those with poor nutritional status or irregular eating habits, and those consuming excessive alcohol should use this medication with special caution. Adverse reactions such as gastrointestinal disturbances, allergic reactions, blood abnormalities, or vitamin B12 deficiency may occur while taking this medication, so symptoms should be reported to a doctor or pharmacist immediately. This medication may interact with other drugs, so healthcare providers must be informed of any concomitant medications, especially those that affect kidney function. Pregnant or breastfeeding women should not take this medication, and switching to insulin therapy is recommended if necessary. When administering to children or the elderly, careful observation and dose adjustments are necessary. Regular monitoring of blood glucose levels is required, and medical staff should be informed immediately of symptoms of hypoglycemia or lactic acidosis. Caution is needed while driving or operating machinery, and it should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. The storage temperature should ideally be maintained at room temperature between 1 to 30 degrees Celsius.
Light pink oblong film-coated tablet
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 500mg · Glimepiride 1mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationMetformin Hydrochloride 500mg · Glimepiride 1mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
CombinationGlimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Hawon Pharmaceutical Co., Ltd.
Metformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
TDS Pharm Co., Ltd.
CombinationGlimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.
CombinationGlimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.